Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 12
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Identification of some bioactive compounds from Trignonella foenumgraecum as possible inhibitors of PPARϒ for diabetes treatment through molecular docking studies, pharmacophore modelling and ADMET profiling: An in-silico study.
Okoh OS, Yakubu A, Adegboyega AE, Uti DE, Obeten UN, Agada SA, Oluwaloni F, Johnson GI, Mela LP, Asomadu RO, Iwaloye O, Johnson TO, Orji OU. Okoh OS, et al. Among authors: iwaloye o. PLoS One. 2023 May 18;18(5):e0284210. doi: 10.1371/journal.pone.0284210. eCollection 2023. PLoS One. 2023. PMID: 37200359 Free PMC article.
Identification of a 1, 8-naphthyridine-containing compound endowed with the inhibition of p53-MDM2/X interaction signaling: a computational perspective.
Olukunle OF, Olowosoke CB, Khalid A, Oke GA, Omoboyede V, Umar HI, Ibrahim O, Adeboboye CF, Iwaloye O, Olawale F, Adedeji AA, Bello T, Alabere HO, Chukwuemeka PO. Olukunle OF, et al. Among authors: iwaloye o. Mol Divers. 2023 Apr 7. doi: 10.1007/s11030-023-10637-3. Online ahead of print. Mol Divers. 2023. PMID: 37029281
A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment.
Johnson TO, Adegboyega AE, Ojo OA, Yusuf AJ, Iwaloye O, Ugwah-Oguejiofor CJ, Asomadu RO, Chukwuma IF, Ejembi SA, Ugwuja EI, Alotaibi SS, Albogami SM, Batiha GE, Rajab BS, Conte-Junior CA. Johnson TO, et al. Among authors: iwaloye o. Front Med (Lausanne). 2022 Jun 15;9:907583. doi: 10.3389/fmed.2022.907583. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35783612 Free PMC article.
24 results